Verzenio is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Abemaciclib.
| Product ID | 0002-4483_268939ac-da7c-4fb5-ba8d-0d59aed8df3f | 
| NDC | 0002-4483 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Verzenio | 
| Generic Name | Abemaciclib | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2017-09-28 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA208716 | 
| Labeler Name | Eli Lilly and Company | 
| Substance Name | ABEMACICLIB | 
| Active Ingredient Strength | 50 mg/1 | 
| Pharm Classes | Kinase Inhibitors [MoA],Kinase Inhibitor [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2017-10-06 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA208716 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-10-06 | 
| Ingredient | Strength | 
|---|---|
| ABEMACICLIB | 50 mg/1 | 
| SPL SET ID: | be4bc0de-0fdc-4d46-8d25-be43c79e6a06 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0002-4483 | Verzenio | abemaciclib | 
| 0002-4815 | Verzenio | abemaciclib | 
| 0002-5337 | Verzenio | abemaciclib | 
| 0002-6216 | Verzenio | abemaciclib | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() VERZENIO  87712095  5746611 Live/Registered  | 
        Eli Lilly and Company  2017-12-07  | 
![]() VERZENIO  87147864  5429204 Live/Registered  | 
        Eli Lilly and Company  2016-08-23  | 
![]() VERZENIO  85864138  not registered Dead/Abandoned  | 
        Eli Lilly and Company  2013-03-01  |